These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16157159)

  • 1. Blood DHEAS concentrations correlate with cognitive function in chronic schizophrenia patients: a pilot study.
    Silver H; Knoll G; Isakov V; Goodman C; Finkelstein Y
    J Psychiatr Res; 2005 Nov; 39(6):569-75. PubMed ID: 16157159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive deficits in schizophrenia are associated with alterations in blood levels of neurosteroids: a multiple regression analysis of findings from a double-blind, randomized, placebo-controlled, crossover trial with DHEA.
    Ritsner MS; Strous RD
    J Psychiatr Res; 2010 Jan; 44(2):75-80. PubMed ID: 19665142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State and trait related predictors of serum cortisol to DHEA(S) molar ratios and hormone concentrations in schizophrenia patients.
    Ritsner M; Gibel A; Maayan R; Ratner Y; Ram E; Modai I; Weizman A
    Eur Neuropsychopharmacol; 2007 Mar; 17(4):257-64. PubMed ID: 17107774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between dehydroepiandrosterone sulfate (DHEAS) and cortisol (CRT) plasma levels and everyday memory in Alzheimer's disease patients compared to healthy controls.
    Carlson LE; Sherwin BB; Chertkow HM
    Horm Behav; 1999 Jun; 35(3):254-63. PubMed ID: 10373337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in DHEA metabolism in schizophrenia: two-month case-control study.
    Ritsner M; Gibel A; Ram E; Maayan R; Weizman A
    Eur Neuropsychopharmacol; 2006 Feb; 16(2):137-46. PubMed ID: 16139994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of cognitive impairment in chronic schizophrenia over brief and intermediate re-test intervals.
    Pietrzak RH; Snyder PJ; Jackson CE; Olver J; Norman T; Piskulic D; Maruff P
    Hum Psychopharmacol; 2009 Mar; 24(2):113-21. PubMed ID: 19090506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced plasma dehydroepiandrosterone sulfate levels are significantly correlated with fatigue severity in patients with primary biliary cirrhosis.
    Ahboucha S; Pomier-Layrargues G; Vincent C; Hassoun Z; Tamaz R; Baker G; Butterworth RF
    Neurochem Int; 2008; 52(4-5):569-74. PubMed ID: 17669554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
    Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
    Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia.
    Kim SW; Shin IS; Kim JM; Lee SH; Lee YH; Yang SJ; Yoon JS
    Hum Psychopharmacol; 2009 Oct; 24(7):565-73. PubMed ID: 19790174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of neurocognitive function in euthymic bipolar patients and stabilized schizophrenic patients.
    Sánchez-Morla EM; Barabash A; Martínez-Vizcaíno V; Tabarés-Seisdedos R; Balanzá-Martínez V; Cabranes-Díaz JA; Baca-Baldomero E; Gómez JL
    Psychiatry Res; 2009 Oct; 169(3):220-8. PubMed ID: 19758705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological impairment in patients with schizophrenia and evidence of hyponatremia and polydipsia.
    Torres IJ; Keedy S; Marlow-O'Connor M; Beenken B; Goldman MB
    Neuropsychology; 2009 May; 23(3):307-14. PubMed ID: 19413445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological profile of cognitively impaired patients with schizophrenia.
    Bozikas VP; Kosmidis MH; Kiosseoglou G; Karavatos A
    Compr Psychiatry; 2006; 47(2):136-43. PubMed ID: 16490572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
    Akdede BB; Anil Yağcioğlu AE; Alptekin K; Turgut TI; Tümüklü M; Yazici MK; Jayathilake K; Tunca Z; Göğüş A; Meltzer HY
    J Clin Psychiatry; 2006 Dec; 67(12):1912-9. PubMed ID: 17194269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of motor dexterity in schizophrenia assessed by a novel finger movement test.
    Midorikawa A; Hashimoto R; Noguchi H; Saitoh O; Kunugi H; Nakamura K
    Psychiatry Res; 2008 Jun; 159(3):281-9. PubMed ID: 18448171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is "clinical" insight the same as "cognitive" insight in schizophrenia?
    Donohoe G; Hayden J; McGlade N; O'Gráda C; Burke T; Barry S; Behan C; Dinan TG; O'Callaghan E; Gill M; Corvin AP
    J Int Neuropsychol Soc; 2009 May; 15(3):471-5. PubMed ID: 19402933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Memory impairment correlates with increased S100B serum concentrations in patients with chronic schizophrenia.
    Pedersen A; Diedrich M; Kaestner F; Koelkebeck K; Ohrmann P; Ponath G; Kipp F; Abel S; Siegmund A; Suslow T; von Eiff C; Arolt V; Rothermundt M
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1789-92. PubMed ID: 18718498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognitive functioning in dually diagnosed middle aged and elderly patients with alcoholism and schizophrenia.
    Mohamed S; Bondi MW; Kasckow JW; Golshan S; Jeste DV
    Int J Geriatr Psychiatry; 2006 Aug; 21(8):711-8. PubMed ID: 16862606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel multidomain computerized cognitive assessment for attention-deficit hyperactivity disorder: evidence for widespread and circumscribed cognitive deficits.
    Leitner Y; Doniger GM; Barak R; Simon ES; Hausdorff JM
    J Child Neurol; 2007 Mar; 22(3):264-76. PubMed ID: 17621495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.